Global Genetic Testing Market
- MAR2978609
- 224 Pages
- July 2018
- Pharmaceuticals
End users
The end users of genetic testing products are mainly hospitals, laboratories and medical research facilities. Decreasing costs of genetic testing products is encouraging more and more individuals to use genetic testing products even without involvement of medical practitioners. This has given rise to a new process called direct-to-consumer genetic testing where the genetic testing product is marketed directly to the individual who wants to be tested.
Market Dynamics
Important growth drivers for the genetic testing market include growing prevalence of genetic disorders and increasing awareness of people about the link between genetic factors and medical conditions. Advances in technology have allowed for the production of painless and minimally invasive genetic testing products which is resulting in growing acceptance and use of the products. Adoption of new technology has also resulted in reduction of the time and cost associated with genetic testing. This has allowed individuals to directly buy and use genetic testing products, giving rise to a process called direct-to-consumer genetic testing.
The genetic testing market also faces a few constraints such as stringent regulations and relatively high time and costs involved. There are also some ethical constraints as genetic testing can be used for negative purposes too. Hence, in order to grow, firms in this market need to produce more affordable products that follow necessary regulations. As genetic testing is a voluntary process, firms must invest in advertising to increase awareness about genetic testing and its benefits.
Market Segmentation
The global genetic testing market can be segmented based on method of testing, purpose of testing, disease targeted, end user and geography. Based on method of testing, the market can be segmented as molecular genetic tests, chromosomal genetic tests and biochemical genetic tests. Based on purpose of testing, products can be of different types like diagnostic, predictive, newborn screening, lineage detection, etc. Based on disease targeted, genetic testing products can be used in cases of cancers, heart diseases, lifestyle diseases, etc.
Regional/Geographic Analysis
Geographically, the genetic testing market can be divided into North America, Europe, Asia-Pacific (APAC), and Latin America, Middle East and Africa (LAMEA) regions. Currently, North America and Europe account for the largest share of the market. There is strong growth potential in other regions as well due to increasing prevalence of lifestyle diseases, rising awareness and increasing disposable incomes.
Key Players
Some of the key players in the genetic testing market are 23andMe, Ranomics, Applied Biosystems, Inc., AutoGenomics Inc., Transgenomic Inc., and others.
The report contains comprehensive analysis on:
--> Genetic Testing Market Segments
--> Genetic Testing Market Drivers, Restraints and Opportunities
--> Genetic Testing Market Size & Forecast 2016 to 2022
--> Supply & Demand Value Chain
--> Genetic Testing Market Current Trends
--> Competition &Major Companies
--> Technology and R&D Status
--> Porters Five Force Analysis
--> Strategic and Critical Success Factor Analysis of Key Players
Regional analysis for Genetic Testing Market includes
--> North America
>> US and Canada
--> Latin America
>> Mexico, Brazil, Argentina and Rest of Latin America
--> Western Europe
>> EU5 (Germany, France, Italy, Spain, U.K.)
>> Nordic Countries (Denmark, Finland, Norway, and Sweden)
>> Benelux (Belgium, The Netherlands, and Luxembourg)
>> Rest of Western Europe
--> Eastern Europe
>> Russia
>> Poland
>> Rest of Eastern Europe
--> Asia Pacific
>> China
>> India
>> Japan
>> Australia and New Zealand
>> Rest of Asia Pacific
--> Middle East and Africa
>> GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)
>> South Africa
>> North Africa
>> Rest of Middle East and Africa
This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides in-depth market segmentation that is derived from extensive product mapping exercises, macro-economic factors and other qualitative and quantitative insights. The impact of all such factors are delivered across multiple market segments and geographies.
Report Highlights::
--> Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)
--> Consumer and Pricing Analysis
--> Market dynamics of the industry
--> In-depth Market Segmentation
--> Historical and Projected Market Sizing in terms of volume and value
--> Recent market trends and Impact Factors
--> R&D Status and Technology Overview
--> Extensive Industry Structure Coverage
1.1. Market Definition
1.2. Market Taxonomy
2. Research Methodology
3. Assumptions and Acronyms
4. Executive Summary
5. Consumer Analysis
5.1. Consumer Profile (Demographic, Geographic, etc.)
5.2. Consumer Motivation
5.3. Procurement Process
5.4. Frequency of Buying
6. Historical Overview (Market Origins, Product Launch
Timeline, etc.)
7. Macroeconomic Factors
7.1. Demography and Healthcare Indicators
7.2. Health Expenditure & Funding
7.3. Incidence OF Genetic Diseases
7.4. Availability, Access and Awareness levels
8. Market Dynamics
8.1. Drivers
8.1.1. Supply Side
8.1.2. Demand Side
8.2. Restraints
8.3. Opportunities
9. R&D Status and Technology Overview
10. Pricing Analysis
11. Regulatory Scenario
12. Case Studies
12.1.Breast and Ovarian Cancer (BRCA1, BRCA2 genes)
12.2.Diet and Fitness – Specialized Role of Genetic Testing
12.3.Treatment of Rare, Inherited Diseases (Sickle Cell
Anemia, cystic fibrosis, etc.)
12.4.Next Generation Sequencing - Emergence and Future
Impact
12.5.Growth of Online Sales
13. Global Genetic Testing Market Analysis, By Test Type
13.1. Introduction
13.2.Prominent Trends
13.3.Regulatory Guidelines
13.4. Market Size and Analysis, By Test Type
13.4.1. Diagnostic Tests
13.4.2. Carrier Tests
13.4.3. Prenatal Testing
13.4.4. Newborn Screening
13.4.5. Preimplantation Testing
13.4.6. Presymptomatic/Predictive Testing
13.4.7. Drug-gene Testing (Pharmacogenomics)
13.4.8. Susceptibility Testing
13.4.9. Nutrigenetic Testing
13.4.10. Forensic, Genetic Relatedness and Ancestry
Testing
13.4.11. Others
13.5.Market Share Analysis and YoY Growth Rates, By Test
Type
14. Global Genetic Testing Market Analysis, By Methodology
14.1. Introduction
14.2.Prominent Trends
14.3. Market Size and Analysis, By Methodology
14.3.1. Single Gene Sequencing
14.3.2. Multi - Gene Panels (Next generation
sequencing (NGS) panels)
14.3.3. Whole Exome/Genome Sequencing
14.3.4. Chromosome Analysis
(Karyotype/Cytogenetic)
14.3.5. Fluorescent In Situ Hybridization (FISH)
14.3.6. Biochemical/biomarker analysis
14.3.7. Others
14.4. Market Share Analysis and YoY Growth Rates, By
Methodology
15. Global Genetic Testing Market Analysis, By Disease Type
15.1. Introduction
15.2. Prominent Trends
15.3. Market Size and Analysis, By Disease Type
15.3.1. Hereditary/Inherited Diseases
15.3.2. Cancers (Tumors)
15.3.3. Others
15.4.Market Share Analysis and YoY Growth Rates, By
Disease Type
16. Global Genetic Testing Market Analysis, By Service
Provider
16.1. Introduction
16.2. Prominent Trends
16.3. Market Size and Analysis, By Service Provider
16.3.1. Hospitals and Diagnostic Centers
16.3.2. Direct-to-Consumer (DTC) Testing
16.4.Market Share Analysis and YoY Growth Rates, By
Service Provider
17. Global Genetic Testing Market Analysis, By Region
17.1.Introduction
17.2.Prominent Trends
17.3.Market Size and Analysis, By Region
17.3.1. North America
17.3.2. Latin America
17.3.3. Europe
17.3.4. Asia Pacific
17.3.5. Middle East & Africa (MEA)
17.4.Market Share Analysis and YoY Growth Rates, By Region
18. North America Genetic Testing Market Analysis
18.1.Introduction
18.2.Prominent Trends
18.3.North America Genetic Testing Market Analysis, by
Country
18.3.1. U.S.
18.3.2. Canada
18.4.North America Genetic Testing Market Analysis, By Test
Type
18.4.1. Diagnostic Tests
18.4.2. Carrier Tests
18.4.3. Prenatal Testing
18.4.4. Newborn Screening
18.4.5. Preimplantation Testing
18.4.6. Presymptomatic/Predictive Testing
18.4.7. Drug-gene Testing (Pharmacogenomics)
18.4.8. Susceptibility Testing
18.4.9. Nutrigenetic Testing
18.4.10. Forensic, Genetic Relatedness and Ancestry
Testing
18.4.11. Others
18.5. North America Genetic Testing Market Size and
Analysis, By Methodology
18.5.1. Single Gene Sequencing
18.5.2. Multi - Gene Panels (Next generation
sequencing (NGS) panels)
18.5.3. Whole Exome/Genome Sequencing
18.5.4. Chromosome Analysis
(Karyotype/Cytogenetic)
18.5.5. Fluorescent In Situ Hybridization (FISH)
18.5.6. Biochemical/biomarker analysis
18.5.7. Others
18.6. North America Genetic Testing Market Size and
Analysis, By Disease Type
18.6.1. Hereditary/Inherited Diseases
18.6.2. Cancers (Tumors)
18.6.3. Others
18.7. North America Genetic Testing Market Size and
Analysis, By Service Provider
18.7.1. Hospitals and Diagnostic Centers
18.7.2. Direct-to-Consumer (DTC) Testing
18.8.Market Share Analysis and YoY Growth Rates
18.8.1. By Country
18.8.2. By Test Type
18.8.3. By Methodology
18.8.4. By Disease Type
18.8.5. By Service Provider
19. Latin America Genetic Testing Market Analysis
19.1.Introduction
19.2.Prominent Trends
19.3.Latin America Genetic Testing Market Analysis, by
Country
19.3.1. Mexico
19.3.2. Brazil
19.3.3. Others
19.4.Latin America Genetic Testing Market Analysis, By Test
Type
19.4.1. Diagnostic Tests
19.4.2. Carrier Tests
19.4.3. Prenatal Testing
19.4.4. Newborn Screening
19.4.5. Preimplantation Testing
19.4.6. Presymptomatic/Predictive Testing
19.4.7. Drug-gene Testing (Pharmacogenomics)
19.4.8. Susceptibility Testing
19.4.9. Nutrigenetic Testing
19.4.10. Forensic, Genetic Relatedness and Ancestry
Testing
19.4.11. Others
19.5. Latin America Genetic Testing Market Size and
Analysis, By Methodology
19.5.1. Single Gene Sequencing
19.5.2. Multi - Gene Panels (Next generation
sequencing (NGS) panels)
19.5.3. Whole Exome/Genome Sequencing
19.5.4. Chromosome Analysis
(Karyotype/Cytogenetic)
19.5.5. Fluorescent In Situ Hybridization (FISH)
19.5.6. Biochemical/biomarker analysis
19.5.7. Others
19.6. Latin America Genetic Testing Market Size and
Analysis, By Disease Type
19.6.1. Hereditary/Inherited Diseases
19.6.2. Cancers (Tumors)
19.6.3. Others
19.7. Latin America Genetic Testing Market Size and
Analysis, By Service Provider
19.7.1. Hospitals and Diagnostic Centers
19.7.2. Direct-to-Consumer (DTC) Testing
19.8.Market Share Analysis and YoY Growth Rates
19.8.1. By Country
19.8.2. By Test Type
19.8.3. By Methodology
19.8.4. By Disease Type
19.8.5. By Service Provider
20. Europe Genetic Testing Market Analysis
20.1.Introduction
20.2.Prominent Trends
20.3.Europe Genetic Testing Market Analysis, by Country
20.3.1. Germany
20.3.2. U.K.
20.3.3. Spain
20.3.4. France
20.3.5. Italy
20.3.6. Russia
20.3.7. Others
20.4.Europe Genetic Testing Market Analysis, By Test Type
20.4.1. Diagnostic Tests
20.4.2. Carrier Tests
20.4.3. Prenatal Testing
20.4.4. Newborn Screening
20.4.5. Preimplantation Testing
20.4.6. Presymptomatic/Predictive Testing
20.4.7. Drug-gene Testing (Pharmacogenomics)
20.4.8. Susceptibility Testing
20.4.9. Nutrigenetic Testing
20.4.10. Forensic, Genetic Relatedness and Ancestry
Testing
20.4.11. Others
20.5. Europe Genetic Testing Market Size and Analysis, By
Methodology
20.5.1. Single Gene Sequencing
20.5.2. Multi - Gene Panels (Next generation
sequencing (NGS) panels)
20.5.3. Whole Exome/Genome Sequencing
20.5.4. Chromosome Analysis
(Karyotype/Cytogenetic)
20.5.5. Fluorescent In Situ Hybridization (FISH)
20.5.6. Biochemical/biomarker analysis
20.5.7. Others
20.6. Europe Genetic Testing Market Size and Analysis, By
Disease Type
20.6.1. Hereditary/Inherited Diseases
20.6.2. Cancers (Tumors)
20.6.3. Others
20.7. Europe Genetic Testing Market Size and Analysis, By
Service Provider
20.7.1. Hospitals and Diagnostic Centers
20.7.2. Direct-to-Consumer (DTC) Testing
20.8.Market Share Analysis and YoY Growth Rates
20.8.1. By Country
20.8.2. By Test Type
20.8.3. By Methodology
20.8.4. By Disease Type
20.8.5. By Service Provider
21. Asia Pacific Genetic Testing Market Analysis
21.1.Introduction
21.2.Prominent Trends
21.3.Asia Pacific Genetic Testing Market Analysis, by Country
21.3.1. India
21.3.2. China
21.3.3. Australia & New Zealand
21.3.4. Japan
21.3.5. Others
21.4.Asia Pacific Genetic Testing Market Analysis, By Test
Type
21.4.1. Diagnostic Tests
21.4.2. Carrier Tests
21.4.3. Prenatal Testing
21.4.4. Newborn Screening
21.4.5. Preimplantation Testing
21.4.6. Presymptomatic/Predictive Testing
21.4.7. Drug-gene Testing (Pharmacogenomics)
21.4.8. Susceptibility Testing
21.4.9. Nutrigenetic Testing
21.4.10. Forensic, Genetic Relatedness and Ancestry
Testing
21.4.11. Others
21.5. Asia Pacific Genetic Testing Market Size and Analysis,
By Methodology
21.5.1. Single Gene Sequencing
21.5.2. Multi - Gene Panels (Next generation
sequencing (NGS) panels)
21.5.3. Whole Exome/Genome Sequencing
21.5.4. Chromosome Analysis
(Karyotype/Cytogenetic)
21.5.5. Fluorescent In Situ Hybridization (FISH)
21.5.6. Biochemical/biomarker analysis
21.5.7. Others
21.6. Asia Pacific Genetic Testing Market Size and Analysis,
By Disease Type
21.6.1. Hereditary/Inherited Diseases
21.6.2. Cancers (Tumors)
21.6.3. Others
21.7. Asia Pacific Genetic Testing Market Size and Analysis,
By Service Provider
21.7.1. Hospitals and Diagnostic Centers
21.7.2. Direct-to-Consumer (DTC) Testing
21.8.Market Share Analysis and YoY Growth Rates
21.8.1. By Country
21.8.2. By Test Type
21.8.3. By Methodology
21.8.4. By Disease Type
21.8.5. By Service Provider
22. Middle East and Africa (MEA) Genetic Testing Market
Analysis
22.1.Introduction
22.2.Prominent Trends
22.3.Middle East and Africa Genetic Testing Market Analysis,
by Country
22.3.1. GCC countries
22.3.2. South Africa
22.3.3. North Africa
22.3.4. Rest of Middle East and Africa
22.4.Middle East and Africa Genetic Testing Market Analysis,
By Test Type
22.4.1. Diagnostic Tests
22.4.2. Carrier Tests
22.4.3. Prenatal Testing
22.4.4. Newborn Screening
22.4.5. Preimplantation Testing
22.4.6. Presymptomatic/Predictive Testing
22.4.7. Drug-gene Testing (Pharmacogenomics)
22.4.8. Susceptibility Testing
22.4.9. Nutrigenetic Testing
22.4.10. Forensic, Genetic Relatedness and Ancestry
Testing
22.4.11. Others
22.5. Middle East and Africa Genetic Testing Market Size and
Analysis, By Methodology
22.5.1. Single Gene Sequencing
22.5.2. Multi - Gene Panels (Next generation
sequencing (NGS) panels)
22.5.3. Whole Exome/Genome Sequencing
22.5.4. Chromosome Analysis
(Karyotype/Cytogenetic)
22.5.5. Fluorescent In Situ Hybridization (FISH)
22.5.6. Biochemical/biomarker analysis
22.5.7. Others
22.6. Middle East and Africa Genetic Testing Market Size and
Analysis, By Disease Type
22.6.1. Hereditary/Inherited Diseases
22.6.2. Cancers (Tumors)
22.6.3. Others
22.7. Middle East and Africa Genetic Testing Market Size and
Analysis, By Service Provider
22.7.1. Hospitals and Diagnostic Centers
22.7.2. Direct-to-Consumer (DTC) Testing
22.8.Market Share Analysis and YoY Growth Rates
22.8.1. By Country
22.8.2. By Test Type
22.8.3. By Methodology
22.8.4. By Disease Type
22.8.5. By Service Provider
23. Industry Structure
23.1. Porters Five Forces Analysis
23.1.1. Bargaining Power of Suppliers
23.1.2. Bargaining Power of Buyers
23.1.3. Threat of New Entrants
23.1.4. Threat of Substitute Products and Services
23.1.5. Internal Rivalry
23.2.Supply Chain Analysis and Profitability Margins
23.3.Market Share Analysis
23.4. Strategic Analysis
23.4.1. Competitive Strategies
23.4.2. Mergers & Acquisitions Activity
23.4.3. Co-operative Agreements
23.5. Critical Success Factor (CSF) Analysis (Technology &
Manufacturing, Design & Features, Brand Reputation,
Distribution Network, Marketing)
23.6.Company Profiles (Overview, Product/Service Details,
Geographic Scope, Financials, Strategic Intent & Approach,
Core Competencies & Competitive Advantage and Key
developments)
23.6.1. 23andme
23.6.2. Counsyl
23.6.3. Quest Diagnostics
23.6.4. Veritas Genetics
23.6.5. MyDNA
23.6.6. deCODE genetics, Inc.
23.6.7. Rosetta Genomics
23.6.8. Ancestry.com Inc.
23.6.9. Illumina, Inc.
23.6.10. Beijing Genomics Institute (BGI)
23.6.11. Gene By Gene, LTD.
23.6.12. Danaher (Cepheid)
23.6.13. Interpace Diagnostics Gr
23.6.14. Myriad Genetics
23.6.15. Qiagen
23.6.16. Centogene AG
23.6.17. Abbott Molecular Inc.
23.6.18. Roche Molecular Diagnostics
24. Prognosis for the Future
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
